Primary Causes & Action Plans

hs-CRP

Systemic inflammation driven by endometriotic tissue
Endometriotic lesions produce inflammatory cytokines, elevating systemic hs-CRP. hs-CRP level correlates with endometriosis severity. Lower hs-CRP indicates reduced disease activity.
Target < 1.0 mg/L
Suggested Action Plan

Lower hs-CRP through Mediterranean diet, omega-3 supplementation (3000-5000 mg EPA/DHA daily), regular exercise, stress management. Retest every 2-3 months to monitor disease activity.

CA-125

Tumor marker associated with endometrial proliferation; elevated in endometriosis
CA-125 is produced by endometrial tissue. Elevated CA-125 correlates with endometriosis burden, especially peritoneal and ovarian disease. Declining CA-125 indicates treatment response.
Target < 35 U/mL
Suggested Action Plan

CA-125 is not specific to endometriosis but tracks disease burden. Monitor alongside hs-CRP. Retest every 3-6 months during treatment.

Estradiol

Endometriotic lesions produce excess estrogen locally; high estradiol drives proliferation
Endometriotic tissue is estrogen-producing and responsive. Elevated estradiol drives tissue proliferation and inflammation. Estradiol suppression is a key treatment goal.
Target Follicular: 30-100 pg/mL. Luteal: 50-150 pg/mL
Suggested Action Plan

Suppress estradiol through low-glycemic diet, exercise, weight loss. Aromatase inhibitors (letrozole) may be used off-label to suppress estradiol in severe cases. Work with gynecologist on dose.

Iron and Ferritin

Iron accumulation in endometriotic lesions and peritoneal fluid drives oxidative stress
Endometriotic lesions accumulate iron, producing oxidative stress and inflammation. Iron chelation and iron control (avoiding excess supplementation) may help. Monitoring ferritin guides intervention.
Target Ferritin: 50-150 ng/mL (aim lower in endometriosis)
Suggested Action Plan

Avoid iron supplementation unless specifically deficient. High-dose iron supplementation may worsen endometriosis. Chelate iron through regular blood donation if ferritin is elevated.

Vitamin D

Critical for immune tolerance and reducing ectopic endometrial growth
Vitamin D deficiency is associated with increased endometriosis severity. Vitamin D promotes regulatory T cells that suppress endometrial proliferation. Optimal vitamin D improves outcomes.
Target > 50 ng/mL
Suggested Action Plan

If deficient, supplement vitamin D3 4000-5000 IU daily. Target 60-80 ng/mL for endometriosis management. Retest in 8-12 weeks.

Getting Started

1
Get Endometriosis Testing and Imaging

Test hs-CRP, CA-125, estradiol, vitamin D, and ferritin. Also order transvaginal ultrasound (better than transabdominal for endometriosis detection). These diagnostics establish baseline disease burden.

2
Adopt Anti-Inflammatory Diet

Mediterranean diet with high omega-3 (fatty fish 2-3x weekly or supplement 3000-5000 mg EPA/DHA daily) and high fiber. Eliminate refined carbohydrates and processed foods. Reduce red meat.

3
Optimize Vitamin D Aggressively

Vitamin D is immunoprotective and suppresses endometrial proliferation. Supplement 4000-5000 IU daily plus sun exposure, targeting 60-80 ng/mL.

4
Consider Hormonal Therapy

Many endometriosis sufferers benefit from continuous hormonal suppression: progestin-only pill, hormonal IUD, or GnRH agonists. Work with gynecologist on whether hormonal therapy is appropriate alongside anti-inflammatory intervention.

5
Retest Every 3-6 Months

hs-CRP and CA-125 should decline with comprehensive anti-inflammatory intervention and hormonal therapy (if used). Retest to confirm disease activity is decreasing.

Why I built this guide.

"Endometriosis-related pain and infertility are largely manageable through comprehensive anti-inflammatory intervention."

Explore More